Citigroup
AGIO icon

Citigroup’s Agios Pharmaceuticals AGIO Stock Holding History

Citigroup’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.13M Buy
62,900
+33,000
+110% +$936K ﹤0.01% 2627
2025
Q4 		$814K Buy
+29,900
New +$1.05M ﹤0.01% 3267
2025
Q2 		– Sell
-60,000
Closed -$1.76M – 5631
2025
Q1 		$1.76M Buy
60,000
+30,000
+100% +$995K ﹤0.01% 2814
2024
Q4 		$986K Buy
30,000
+4,300
+17% +$202K ﹤0.01% 3379
2024
Q3 		$1.14M Buy
+25,700
New +$1.17M ﹤0.01% 3162
2024
Q2 		– Sell
-26,800
Closed -$784K – 5560
2024
Q1 		$784K Sell
26,800
-2,000
-7% -$53.6K ﹤0.01% 3217
2023
Q4 		$641K Sell
28,800
-29,900
-51% -$670K ﹤0.01% 3218
2023
Q3 		$1.45M Buy
58,700
+28,800
+96% +$762K ﹤0.01% 2230
2023
Q2 		$847K Buy
29,900
+100
+0.3% +$2.49K ﹤0.01% 2969
2023
Q1 		$685K Sell
29,800
-30,200
-50% -$802K ﹤0.01% 2871
2022
Q4 		$1.68M Buy
60,000
+10,400
+21% +$293K ﹤0.01% 2175
2022
Q3 		$1.4M Buy
49,600
+30,000
+153% +$805K ﹤0.01% 2447
2022
Q2 		$435K Sell
19,600
-10,300
-34% -$233K ﹤0.01% 3335
2022
Q1 		$870K Buy
+29,900
New +$914K ﹤0.01% 3099
2020
Q4 		– Sell
-1,300
Closed -$46K – 7331
2020
Q3 		$46K Sell
1,300
-3,700
-74% -$162K ﹤0.01% 5656
2020
Q2 		$267K Sell
5,000
-2,800
-36% -$130K ﹤0.01% 4793
2020
Q1 		$277K Sell
7,800
-600
-7% -$27.7K ﹤0.01% 4443
2019
Q4 		$401K Buy
8,400
+4,500
+115% +$170K ﹤0.01% 4620
2019
Q3 		$126K Sell
3,900
-1,300
-25% -$53.8K ﹤0.01% 5505
2019
Q2 		$259K Sell
5,200
-8,500
-62% -$454K ﹤0.01% 5033
2019
Q1 		$924K Buy
13,700
+500
+4% +$29.1K ﹤0.01% 3495
2018
Q4 		$609K Sell
13,200
-18,500
-58% -$1.14M ﹤0.01% 3920
2018
Q3 		$2.44M Buy
31,700
+7,900
+33% +$636K ﹤0.01% 2548
2018
Q2 		$2M Buy
23,800
+9,500
+66% +$828K ﹤0.01% 2678
2018
Q1 		$1.17M Buy
14,300
+11,700
+450% +$904K ﹤0.01% 3100
2017
Q4 		$149K Sell
2,600
-1,900
-42% -$120K ﹤0.01% 5295
2017
Q3 		$300K Buy
4,500
+1,800
+67% +$108K ﹤0.01% 4616
2017
Q2 		$139K Buy
2,700
+500
+23% +$25.6K ﹤0.01% 5080
2017
Q1 		$128K Sell
2,200
-1,500
-41% -$71.9K ﹤0.01% 5021
2016
Q4 		$154K Sell
3,700
-5,500
-60% -$289K ﹤0.01% 5493
2016
Q3 		$486K Sell
9,200
-5,000
-35% -$218K ﹤0.01% 3918
2016
Q2 		$595K Buy
14,200
+4,700
+49% +$232K ﹤0.01% 3471
2016
Q1 		$386K Buy
9,500
+7,700
+428% +$329K ﹤0.01% 4418
2015
Q4 		$117K Sell
1,800
-4,100
-69% -$269K ﹤0.01% 5247
2015
Q3 		$416K Sell
5,900
-500
-8% -$48.9K ﹤0.01% 3925
2015
Q2 		$711K Buy
+6,400
New +$689K ﹤0.01% 3401

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Citigroup's AGIO Position: Q1 2026 in Review

Citigroup reduced its Agios Pharmaceuticals (AGIO) stake by 81% in Q1 2026, selling an estimated $2.02M and leaving 17,096 shares worth $578K. The position accounts for ﹤0.01% of the portfolio, ranked #3458.

Citigroup first reported a position in AGIO in Q3 2013 and has held it in 50 quarters since. The position peaked at $7.77M in Q3 2020. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Citigroup held 17,096 shares of Agios Pharmaceuticals worth $578K as of Q1 2026.
  • Citigroup sold 71,142 Agios Pharmaceuticals shares in Q1 2026, an estimated $2.02M.
  • Agios Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3458 holding.
  • Citigroup first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 50 quarters since.
  • Citigroup's Agios Pharmaceuticals position peaked at $7.77M in Q3 2020.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.